GlassScriptPhysician profile
Binzhi Zhang
NPI 1659692861
$2,776.81
in general payments reported to CMS, 2019-2025
26 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $97.80 · 2021: $54.86 · 2022: $184 · 2023: $414 · 2024: $760 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.67 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $685.88 | 2019-2025 | Collagenase Santyl, Acticoat 4" X 4", Iodosorb Ointment 40g USA |
| Solventum Corporation | $347.75 | 2024-2025 | Activ.A.C., Prevena, V.A.C. Dermatac |
| Abbvie INC. | $221.08 | 2021-2024 | Dalvance |
| Bard Peripheral Vascular, INC. | $136.93 | 2024 | Venovo |
| Convatec INC. | $130.85 | 2019-2024 | |
| Boston Scientific Corporation | $127.40 | 2024 | |
| Abbott Laboratories | $124.35 | 2019 | |
| Glaxosmithkline, LLC. | $114.06 | 2023 | Shingrix |
| Nuwellis, INC. | $109.54 | 2019 | |
| Silk Road Medical, INC. | $101.67 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.27 | 2023 | Lifevest |
| Novo Nordisk INC | $92.43 | 2019 | |
| Leo Pharma INC. | $62.95 | 2025 | Spevigo |
| Organogenesis INC. | $61.09 | 2020-2025 | Apligraf |
| Kerecis Limited | $60.73 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $58.79 | 2019 | |
| Urgo Medical North America, LLC | $55.98 | 2024-2025 | Urgoclean Ag, Urgok2 |
| Hartmann USA, INC. | $31.98 | 2022-2024 | Zetuvit Plus 10x10 P10 |
| Medline Industries LP | $30.93 | 2022 | |
| Mimedx Group, INC. | $28.49 | 2024-2025 | |
| Bioventus LLC | $24.64 | 2022 | |
| Misonix INC | $16.50 | 2020 | |
| Ovik Health, LLC | $16.27 | 2024 | Coflex Tlc |
| Paratek Pharmaceuticals, INC. | $14.39 | 2020 | |
| Coloplast Corp | $13.85 | 2024 | |
| Medtronic Vascular, INC. | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Binzhi Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.